The Gross Margin of Zymeworks Inc. (ZYME) is
7775.20%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date |
Value |
| 2025-12-31 |
7775.20%
|
| Ticker |
Name |
Value |
|
REPL
|
Replimune Group, Inc.
|
7775.20%
|
|
NKTX
|
Nkarta, Inc.
|
7775.20%
|
|
STTK
|
Shattuck Labs Inc
|
7775.20%
|
|
SVA.V
|
Sernova Corp
|
44.44%
|
|
TH.TO
|
Theratechnologies Inc
|
76.19%
|
|
DMTK
|
DermTech Inc
|
1.80%
|
|
EPIX
|
ESSA Pharma Inc
|
7775.20%
|
|
FUSN
|
Fusion Pharmaceuticals Inc
|
7775.20%
|
|
VBIV
|
VBI Vaccines Inc
|
-44.06%
|
|
ALEC
|
Alector, Inc.
|
7775.20%
|
|
APS.TO
|
Aptose Biosciences Inc
|
100.00%
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
90.24%
|
|
GBIO
|
Generation Bio Co
|
7775.20%
|
|
IMVT
|
Immunovant, Inc.
|
7775.20%
|
|
KRON
|
Kronos Bio LLC
|
7775.20%
|
|
KRYS
|
Krystal Biotech, Inc.
|
94.08%
|
|
ALVR
|
Allovir Inc
|
7775.20%
|
|
CMPS
|
Compass Pathways PLC
|
7775.20%
|
|
CYTK
|
Cytokinetics, Incorporated
|
7775.20%
|
|
QURE
|
uniQure N.V.
|
89.53%
|
|
STOK
|
Stoke Therapeutics, Inc.
|
7775.20%
|
|
KNTE
|
Kinnate Biopharma Inc
|
7775.20%
|
|
YMAB
|
Y-mAbs Therapeutics Inc
|
82.89%
|
|
KURA
|
Kura Oncology, Inc.
|
99.92%
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
7775.20%
|
|
OCGN
|
Ocugen, Inc.
|
7775.20%
|
|
PMVP
|
Pmv Pharmaceuticals, Inc
|
7775.20%
|
|
RPTX
|
Repare Therapeutics Inc
|
11.46%
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
7775.20%
|
|
CCCC
|
C4 Therapeutics, Inc.
|
7775.20%
|
|
KROS
|
Keros Therapeutics, Inc.
|
7775.20%
|
|
OLMA
|
Olema Pharmaceuticals, Inc.
|
7775.20%
|